Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term colorectal-cancer. Found 50 abstracts

no pagination
Khrizman P, Niland JC, ter Veer A, Milne D, Dunn KB, Carson WE, Engstrom PF, Shibata S, Skibber JM, Weiser MR, Schrag D, Benson AB. Postoperative Adjuvant Chemotherapy Use in Patients With Stage II/III Rectal Cancer Treated With Neoadjuvant Therapy: A National Comprehensive Cancer Network Analysis. Journal of Clinical Oncology. 2013 Jan;31(1):30-8.
de Jesus-Gonzalez N, Robinson E, Penchev R, von Mehren M, Heinrich MC, Tap W, Wang Q, Demetri G, George S, Humphreys BD. Regorafenib Induces Rapid and Reversible Changes in Plasma Nitric Oxide and Endothelin-1. American Journal of Hypertension. 2012 Oct;25(10):1118-23.   PMCID: PMC 3578478
Martin LP, Kozloff MF, Herbst RS, Samuel TA, Kim S, Rosbrook B, Tortorici M, Chen Y, Tarazi J, Olszanski AJ, Rado T, Starr A, Cohen RB. Phase I study of axitinib combined with paclitaxel, docetaxel or capecitabine in patients with advanced solid tumours. British Journal of Cancer. 2012 Oct;107(8):1268-76.
Martin LP, Kozloff MF, Herbst RS, Samuel TA, Kim S, Rosbrook B, Tortorici M, Chen Y, Tarazi J, Olszanski AJ, Rado T, Starr A, Cohen RB. Phase I study of axitinib combined with paclitaxel, docetaxel or capecitabine in patients with advanced solid tumours. British Journal of Cancer. 2012 Oct;107(8):1268-76.   PMCID: PMC3494424
Patson B, Cohen RB, Olszanski AJ. Pharmacokinetic evaluation of axitinib. Expert Opinion on Drug Metabolism & Toxicology. 2012 Feb;8(2):259-70.   PMCID: not NIH funded
Wong YN, Litwin S, Vaughn D, Cohen S, Plimack ER, Lee J, Song W, Dabrow M, Brody M, Tuttle H, Hudes G. Phase II Trial of Cetuximab With or Without Paclitaxel in Patients With Advanced Urothelial Tract Carcinoma. Journal of Clinical Oncology. 2012 Oct;30(28):3545-51.   PMCID: PMC3454772
Astsaturov IA, Meropol NJ, Alpaugh RK, Burtness BA, Cheng JD, McLaughlin S, Rogatko A, Xu ZH, Watson JC, Weiner LM, Cohen SJ. Phase II and Coagulation Cascade Biomarker Study of Bevacizumab With or Without Docetaxel in Patients With Previously Treated Metastatic Pancreatic Adenocarcinoma. American Journal of Clinical Oncology-Cancer Clinical Trials. 2011 Feb;34(1):70-5.   PMCID: PMC3030655
Farley J, Sill MW, Birrer M, Walker J, Schilder RJ, Thigpen JT, Coleman RL, Miller BE, Rose PG, Lankes HA. Phase II study of cisplatin plus cetuximab in advanced, recurrent, and previously treated cancers of the cervix and evaluation of epidermal growth factor receptor immunohistochemical expression: A Gynecologic Oncology Group study. Gynecologic Oncology. 2011 May;121(2):303-8.   PMCID: PMC3081894
Hall MJ, Manne SL, Winkel G, Chung DS, Weinberg DS, Meropol NJ. Effects of a Decision Support Intervention on Decisional Conflict Associated with Microsatellite Instability Testing. Cancer Epidemiology Biomarkers & Prevention. 2011 Feb;20(2):249-54.   PMCID: PMC3076798
Hernandez JM, Farma JM, Coppola D, Hakam A, Fulp WJ, Chen DT, Siegel EM, Yeatman TJ, Shibata D. Expression of the Antiapoptotic Protein Survivin in Colon Cancer. Clinical Colorectal Cancer. 2011 Sep;10(3):188-93.   PMCID: not NIH funded
Hoffman AM, Cairns P. Epigenetics of kidney cancer and bladder cancer. Epigenomics. 2011 Feb;3(1):19-34.   PMCID: NIHMS362391
Li Y, Bavarva JH, Wang Z, Guo J, Qian C, Thibodeau SN, Golemis EA, Liu W. HEF1, a novel target of Wnt signaling, promotes colonic cell migration and cancer progression. Oncogene. 2011 Jun;30(23):2633-43.   PMCID: PMC164309
O'Grady MA, Slater E, Sigurdson ER, Meropol NJ, Weinstein A, Lusch CJ, Sein E, Keeley P, Miller B, Engstrom PF, Cohen SJ. Assessing Compliance with National Comprehensive Cancer Network Guidelines for Elderly Patients with Stage III Colon Cancer: The Fox Chase Cancer Center Partners' Initiative. Clinical Colorectal Cancer. 2011 Jun;10(2):113-6.   PMCID: PMC3388796
Pectasides E, Rampias T, Kountourakis P, Sasaki C, Kowalski D, Fountzilas G, Zaramboukas T, Rimm D, Burtness B, Psyrri A. Comparative Prognostic Value of Epidermal Growth Factor Quantitative Protein Expression Compared with FISH for Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research. 2011 May;17(9):2947-54.   PMCID: not NIH funded
Wang C, Gallo RE, Fleisher L, Miller SM. Literacy Assessment of Family Health History Tools for Public Health Prevention. Public Health Genomics. 2011 Jan;14(4-5):222-37.   PMCID: PMC2891255
Coups EJ, Geller AC, Weinstock MA, Heckman CJ, Manne SL. Prevalence and Correlates of Skin Cancer Screening among Middle-aged and Older White Adults in the United States. American Journal of Medicine. 2010 May;123(5):439-45.   PMCID: PMCID: PMC2858071 [Available on 2011/5/1]
Lee JJ, Natsuizaka M, Ohashi S, Wong GS, Takaoka M, Michaylira CZ, Budo D, Tobias JW, Kanai M, Shirakawa Y, Naomoto Y, Klein-Szanto AJ, Haase VH, Nakagawa H. Hypoxia activates the cyclooxygenase-2-prostaglandin E synthase axis. Carcinogenesis. 2010 Mar;31(3):427-34.   PMCID: PMC2832548 (available on 3/1/2010)
Manne S, Jacobsen PB, Ming ME, Winkel G, Dessureault S, Lessin SR. Tailored Versus Generic Interventions for Skin Cancer Risk Reduction for Family Members of Melanoma Patients. Health Psychology. 2010 Nov;29(6):583-93.   PMCID: PMC3058834
Mego M, Mani SA, Cristofanilli M. Molecular mechanisms of metastasis in breast cancer-clinical applications. Nature Reviews Clinical Oncology. 2010 Dec;7(12):693-701.
Molatore S, Russo MT, D'Agostino VG, Barone F, Matsumoto Y, Albertini AM, Minoprio A, Degan P, Mazzei F, Bignami M, Ranzani GN. MUTYH Mutations Associated with Familial Adenomatous Polyposis: Functional Characterization by a Mammalian Cell-Based Assay. Human Mutation. 2010 Feb;31(2):159-66.   PMCID: not NIH funded
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term colorectal-cancer

colorectal-cancer bevacizumab angiogenesis renal-cell carcinoma growth cell lung-cancer survival clinical-trials chemotherapy squamous-cell carcinoma lung-cancer information gene ag-013736 1990 lkman j-journal of the national cancer institute-v82-p4 Colon cancer combination messenger-rna breast-cancer germline mutations paclitaxel axitinib-docetaxel-capecitabine-solid tumours metastatic breast-cancer expression endothelial growth-factor pharmacokinetics trial receptors antitumor-activity carcinoma metastatic dna methylation 1969 laughlin gh-v12-p639 mutations targeting survivin receptor gemcitabine progression society family members phase-ii contrast-enhanced mri hypertension trials diastolic blood-pressure health maintenance organization renal cell Survivin task-force glycosylase activity bladder-cancer young-women Performance plus gemcitabine tumor-suppressor gene general-practice care Apoptosis plus cetuximab oxidative dna-damage inducible factor-1-alpha k-ras activation e-cadherin VEGF clinical documentation ulcerative-colitis solid tumors preoperative chemoradiation aberrant promoter susceptibility pancreatic adenocarcinoma plasma-levels Gerontologic oncology transcriptional regulation Quality prevention practices gastric-cancer model plus irinotecan pathway patterns MUTYH gene mutations MUTYH-associated polyposis-functional analysis-mammalian cell assay-unclassified variants blood pressure antiangiogenic therapy-endothelin-1-hypertension-nitric oxide surgery up-regulation gastrointestinal stromal tumors Cisplatin coagulation angiogenesis inhibitor uterine cervix inherited variants identification copy number alterations monoclonal-antibody c225 phase-ii trial system behavior inhibitor amplification circulating tumor-cells formula tissue microarray analysis cutaneous melanoma melanoma patients promoter hypermethylation cancer-cells Immunohistochemistry transcriptional activity carcinomas Family health history women bladder cancer metaanalysis older primary-care growth-factor oxaliplatin transitional-cell carcinoma induced apoptosis readability 2nd-line treatment primary-care physicians questionnaire genetics prostaglandin-e synthase-1 Wnt signaling HEF1-colorectal cancer-tumorigenesis risk-assessment-tool biomarker 2-stage designs biallelic mutations vascular endothelial growth factor Cervical cancer Health Document complexity growth-factor-receptor sun protection localization age cpg-island methylation mesenchymal transition Genetic literacy prostaglandin e-2 blood-pressure inhibitor sunitinib AG-013736 esophageal epithelial-cells prognostic-factors clear-cell pathways knowledge literacy
Last updated on Friday, July 10, 2020